Sutro Biopharma, Inc. (STRO)
24.45
-0.09
(-0.37%)
USD |
NASDAQ |
Mar 12, 16:00
23.01
-1.44
(-5.89%)
Pre-Market: 08:40
Sutro Biopharma EPS Diluted (Quarterly) : -6.699 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| GT Biopharma, Inc. | -4.413 |
| Rhythm Pharmaceuticals, Inc. | -0.7302 |
| Crinetics Pharmaceuticals, Inc. | -1.292 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.86M |
| Revenue (Quarterly) | 9.693M |
| Total Expenses (Quarterly) | 66.55M |
| Enterprise Value | 268.24M |
| Gross Profit Margin (Quarterly) | 80.40% |
| Profit Margin (Quarterly) | -586.6% |
| Earnings Yield | -72.60% |
| Normalized Earnings Yield | -62.42 |